Home/Oncovita/Frédéric Tangy
FT

Frédéric Tangy

Co-Founder and Chief Scientific Officer

Oncovita

Therapeutic Areas

Oncovita Pipeline

DrugIndicationPhase
MVdeltaCPleural MesotheliomaPre-clinical
Measovir®-based candidateBladder CancerPre-clinical
Measovir®-based Prophylactic Vaccine (with Unither)UndisclosedResearch/Pre-clinical